NCI

The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.

Learn how the Precision Cancer Medicine Initiative is advancing research, extending lives, and breaking down barriers to access.

Christopher Counter, PhD, associate director of Basic Research, is a member of a group receiving an international Cancer Grand Challenges Grant to investigate origins of cancer.

Clinical providers, researchers, staff & health leaders came together to celebrate the 50th anniversary of the Duke Comprehensive Cancer Center (now DCI).

Gloria Bass, MA, has been a part of the Duke Health family for 41 years, including 26 years at DCI.

As Duke celebrates its 50th anniversary of transforming cancer discovery and care, researchers and providers look toward the next half century. 

The $1.2 million award from the NIH/NCI Intervention and Surveillance Modeling Network is to study ways of reducing uterine cancer mortality.

NCI welcomes the Duke BioRepository & Precision Pathology Center as the new site of the Southern Division of the Cooperative Human Tissue Network.

The National Cancer Institute has created new pages on its website related to the rapidly evolving COVID-19 situation: one for patients and one for researchers.

Good news about Duke Cancer Institute's continued recognition as a leader in cancer research and care, and new investments in immunotherapy.

After many months of preparation and an extensive review process, DCI was renewed as an NCI-designated Comprehensive Cancer Center for another five-year period.